Intensified research in this field showed that of the genes located on the 9p21 deletion and promoter, hypermethylation of CDKN2A and CDKN2B genes has been observed in more than 70% of T-ALL patients. This evidence concerns the gene CDKN2A and acute lymphoblastic leukemia.